icon-folder.gif   Conference Reports for NaTaP  
 
  EASL - The International Liver Congress 2015
50th annual Meeting of the European
association for the Study of the Liver
Vienna, austria  april 22-26
Back grey_arrow_rt.gif
 
 
 
Long-Term Persistence of HCV NS5A Variants After
Treatment With NS5A Inhibitor Ledipasvir

 
 
  Reported by Jules Levin
EASL 2015 April 22-26 Vienna Austria
 
David Wyles1, Alessandra Mangia2, Wendy Cheng3, Stephen Shafran4, Christian Schwabe5, Wen Ouyang6, Krishna Chodavarapu6, John McNally6, Brian Doehle6 , Evguenia Svarovskaia6, Michael D. Miller6, Hongmei Mo6, Hadas Dvory-Sobol6
 
1University of California San Diego, California, USA; 2Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo, Italy; 3Royal Perth Hospital, Western Australia, Australia; 4University of Alberta, Edmonton, Canada; 5Auckland Clinical Studies Ltd, Auckland, New Zealand; 6Gilead Sciences, Inc., Foster City, California, USA

EASL1.gif

EASL2.gif

EASL3.gif

EASL4.gif

EASL5.gif

EASL6.gif

EASL7.gif

EASL8.gif